Now instead of looking at a media summary with a clickbait headline, let's look at the actual data (or the few there are): this was a RCT designed to show efficacy against symptomatic disease on young people (18-65 yo) without HIV or other severe comorbidites. It was not designed to assess against severe disease, as the ~1700 volunteers were healthy: no hypertension, no diabetes, no respiratory issues. 42 cases of COVID occured, mostly mild and some moderates. So no significant reduction for moderate/mild illness but with a very large confidence interval (-50 to 59.8), due to the small sample size.



Conclusion: this study suffers from a small sample size, thus is inconclusive.